Atossa Therapeutics
ATOS
#9245
Rank
C$0.14 B
Marketcap
C$1.12
Share price
3.47%
Change (1 day)
-36.78%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -C$40.02 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$35.32 Million, an increase over its 2023 earnings that were of -C$41.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$40.02 Million13.3%
2024 -C$35.32 Million-15.25%
2023 -C$41.68 Million11.62%
2022 -C$37.34 Million30.84%
2021 -C$28.54 Million15.58%
2020 -C$24.69 Million3.41%
2019 -C$23.88 Million51.16%
2018 -C$15.8 Million40.41%
2017 -C$11.25 Million27.54%
2016 -C$8.82 Million-47.49%
2015 -C$16.8 Million-17.25%
2014 -C$20.3 Million35.91%
2013 -C$14.94 Million112.3%
2012 -C$7.04 Million46.53%
2011 -C$4.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.86 B-112,907.30%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$1.84 B-4,742.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$1.78 B-4,581.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-C$10.86 Million-72.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
C$57.71 M-245.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-C$0.16 Billion 280.29%๐Ÿ‡บ๐Ÿ‡ธ USA